433 related articles for article (PubMed ID: 18710756)
1. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
[TBL] [Abstract][Full Text] [Related]
2. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
[TBL] [Abstract][Full Text] [Related]
3. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
4. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
Ashley R; Vandersteen D
J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
Friedmacher F; Colhoun E; Puri P
J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection.
Traxel E; DeFoor W; Reddy P; Sheldon C; Minevich E
J Urol; 2009 Oct; 182(4 Suppl):1708-12. PubMed ID: 19692024
[TBL] [Abstract][Full Text] [Related]
8. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.
Chi A; Gupta A; Snodgrass W
J Urol; 2008 May; 179(5):1966-9. PubMed ID: 18355849
[TBL] [Abstract][Full Text] [Related]
9. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
Puri P; Kutasy B; Colhoun E; Hunziker M
J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
[TBL] [Abstract][Full Text] [Related]
10. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation.
Elmore JM; Kirsch AJ; Heiss EA; Gilchrist A; Scherz HC
J Urol; 2008 Jun; 179(6):2364-7; discussion 2367-8. PubMed ID: 18436248
[TBL] [Abstract][Full Text] [Related]
11. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux.
Kajbafzadeh AM; Tourchi A
J Urol; 2012 Sep; 188(3):948-52. PubMed ID: 22819104
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
Cerwinka WH; Scherz HC; Kirsch AJ
J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
[TBL] [Abstract][Full Text] [Related]
17. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Moore K; Bolduc S
J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
[TBL] [Abstract][Full Text] [Related]
20. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.
Cerwinka WH; Qian J; Easley KA; Scherz HC; Kirsch AJ
J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
